Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
June-2018 Volume 15 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
June-2018 Volume 15 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Role of plasminogen activator inhibitor‑1 in the diagnosis and prognosis of patients with Parkinson's disease

  • Authors:
    • Hong Pan
    • Ying Zhao
    • Zhengping Zhai
    • Jinyu Zheng
    • Yong Zhou
    • Qijin Zhai
    • Xiangyang Cao
    • Jisha Tian
    • Liandong Zhao
  • View Affiliations / Copyright

    Affiliations: Department of Neurology, Huai'an Second People's Hospital, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, Jiangsu 223002, P.R. China, Department of Neurology, Lianshui County People's Hospital, Huai'an, Jiangsu 223002, P.R. China, Department of Neurosurgery, Huai'an Second People's Hospital, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, Jiangsu 223002, P.R. China
  • Pages: 5517-5522
    |
    Published online on: April 17, 2018
       https://doi.org/10.3892/etm.2018.6076
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Parkinson's disease is a neurodegenerative disease that frequently results in memory disorders, cognitive decline and dementia. Previous studies have reported that plasminogen activator inhibitor‑1 (PAI‑1) serves an important role in cardiovascular disease risk, adiposity, insulin resistance and inflammation. However, the role of PAI‑1 in diagnosis and prognosis of patients with Parkinson's disease following deep brain stimulation (DBS) has not reported, to the best of our knowledge. Therefore, the purpose of the present study was to investigate the clinical significance of PAI‑1 in patients with Parkinson's disease. Plasma PAI‑1 levels were measured in 102 patients with Parkinson's disease who underwent DBS. It was demonstrated that plasma PAI‑1 levels were significantly increased in patients with Parkinson's disease compared with healthy individuals (P<0.01). Patients with Parkinson's disease received DBS presented significantly improved cognitive competence compared with controls (P<0.01). DBS significantly decreased plasma PAI‑1 levels in patients with Parkinson's disease compared with controls (P<0.05). It was also observed that plasma PAI‑1 levels were significantly negatively associated with cognitive function for patients with Parkinson's disease (P<0.01). In conclusion, these findings demonstrated that the degree of Parkinson's disease severity is positively associated with circulating levels of plasma PAI‑1 levels, which suggests that PAI‑1 may be a potential diagnostic and prognostic marker for patients with Parkinson's disease.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

View References

1 

Mano T, Britton Z and Britton T: Anatomo-functional basis of nonmotor symptoms in Parkinson disease. Neurology. 87:2506–2507. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Meles SK, Teune LK, de Jong BM, Dierckx RA and Leenders KL: Metabolic Imaging in Parkinson disease. J Nuclear Med. 58:23–28. 2017. View Article : Google Scholar

3 

Cooper CA and Chahine LM: Biomarkers in prodromal Parkinson disease: A qualitative review. J Int Neuropsychol Soc. 22:956–967. 2016. View Article : Google Scholar : PubMed/NCBI

4 

Chiou SM, Lin YC, Lu MK and Tsai CH: Bilateral subthalamic stimulation for advanced Parkinson disease: Early experience at an Eastern center. Neurol Sci. 36:515–520. 2015. View Article : Google Scholar : PubMed/NCBI

5 

Nowacka B, Lubinski W, Honczarenko K, Potemkowski A and Safranow K: Ophthalmological features of Parkinson disease. Med Sci Monit. 20:2243–2249. 2014. View Article : Google Scholar : PubMed/NCBI

6 

Elstein D, Alcalay R and Zimran A: The emergence of Parkinson disease among patients with Gaucher disease. Best Pract Res Clin Endocrinol Metab. 29:249–259. 2015. View Article : Google Scholar : PubMed/NCBI

7 

Liang HW, Huang YP and Pan SL: Parkinson disease and risk of acute myocardial infarction: A population-based, propensity score-matched, longitudinal follow-up study. Am Heart J. 169:508–514. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Gorska-Ciebiada M, Saryusz-Wolska M, Borkowska A, Ciebiada M and Loba J: Plasma levels of thrombomodulin, plasminogen activator inhibitor-1 and fibrinogen in elderly, diabetic patients with depressive symptoms. Aging Clin Exp Res. 28:843–851. 2016. View Article : Google Scholar : PubMed/NCBI

9 

Gettins PG and Dolmer K: The high affinity binding site on plasminogen activator Inhibitor-1 (PAI-1) for the low density lipoprotein receptor-related protein (LRP1) is composed of four basic residues. J Biol Chem. 291:800–812. 2016. View Article : Google Scholar : PubMed/NCBI

10 

Xu F, Liu H and Sun Y: Association of plasminogen activator inhibitor-1 gene polymorphism and type 2 diabetic nephropathy. Ren Fail. 38:157–162. 2016. View Article : Google Scholar : PubMed/NCBI

11 

Zhou X, Hendrickx ML, Hassanzadeh-Ghassabeh G, Muyldermans S and Declerck PJ: Generation and in vitro characterisation of inhibitory nanobodies towards plasminogen activator inhibitor 1. Thromb Haemost. 116:1032–1040. 2016. View Article : Google Scholar : PubMed/NCBI

12 

Shenai MB, Patel DM, Romeo A, Whisenhunt JD, Walker HC, Guthrie S and Guthrie BL: The relationship of electrophysiologic subthalamic nucleus length as a predictor of outcomes in deep brain stimulation for parkinson disease. Stereotact Funct Neurosurg. 95:341–347. 2017. View Article : Google Scholar : PubMed/NCBI

13 

Correction: Using canadian primary care sentinel Surveillance Network data to examine depression in patients with a diagnosis of Parkinson disease: A retrospective cohort study. CMAJ Open. 4:E7192016. View Article : Google Scholar : PubMed/NCBI

14 

Kataoka H, Tanaka N, Eng M, Saeki K, Kiriyama T, Eura N, Ikeda M, Izumi T, Kitauti T, Furiya Y, et al: Risk of falling in Parkinson's disease at the Hoehn-Yahr stage III. Eur Neurol. 66:298–304. 2011. View Article : Google Scholar : PubMed/NCBI

15 

Yehya A, Ghuloum S, Mahfoud Z, Opler M, Khan A, Hammoudeh S, Abdulhakam A, Al-Mujalli A, Hani Y, Elsherbiny R and Al-Amin H: Validity and reliability of the arabic version of the positive and negative syndrome scale. Psychopathology. 49:181–187. 2016. View Article : Google Scholar : PubMed/NCBI

16 

Nunes PM, Wright AJ, Veltien A, van Asten JJ, Tack CJ, Jones JG and Heerschap A: Dietary lipids do not contribute to the higher hepatic triglyceride levels of fructose-compared to glucose-fed mice. FASEB J. 28:1988–1997. 2014. View Article : Google Scholar : PubMed/NCBI

17 

Pelletier S, Nalpas B, Alarcon R, Rigole H and Perney P: Investigation of cognitive improvement in alcohol-dependent inpatients using the montreal cognitive assessment (MoCA) score. J Addict. 2016:15390962016.PubMed/NCBI

18 

McIntosh S and Adams J: Anxiety and quality of recovery in day surgery: A questionnaire study using Hospital Anxiety and depression scale and quality of recovery score. Int J Nurs Pract. 17:85–92. 2011. View Article : Google Scholar : PubMed/NCBI

19 

Guimaraes-Pereira L, Costa M, Sousa G and Abelha F: Quality of recovery after anaesthesia measured with QoR-40: A prospective observational study. Braz J Anesthesiol. 66:369–375. 2016.PubMed/NCBI

20 

Wieser MJ, Klupp E, Weyers P, Pauli P, Weise D, Zeller D, Classen J and Mühlberger A: Reduced early visual emotion discrimination as an index of diminished emotion processing in Parkinson's disease?-Evidence from event-related brain potentials. Cortex. 48:1207–1217. 2012. View Article : Google Scholar : PubMed/NCBI

21 

Hayes AF and Rockwood NJ: Regression-based statistical mediation and moderation analysis in clinical research: Observations, recommendations, and implementation. Behav Res Ther. 98:39–57. 2017. View Article : Google Scholar : PubMed/NCBI

22 

Kovacs M, Makkos A, Weintraut R, Karadi K, Janszky J and Kovacs N: Prevalence of anxiety among hungarian subjects with Parkinson's disease. Behav Neurol. 2017:14701492017. View Article : Google Scholar : PubMed/NCBI

23 

Tholfsen LK, Larsen JP, Schulz J, Tysnes OB and Gjerstad MD: Changes in insomnia subtypes in early Parkinson disease. Neurology. 88:352–358. 2017. View Article : Google Scholar : PubMed/NCBI

24 

Wyman-Chick KA, Martin PK, Minár M and Schroeder RW: Cognition in patients with a clinical diagnosis of Parkinson disease and scans without evidence of dopaminergic deficit (SWEDD): 2-year follow-up. Cogn Behav Neurol. 29:190–196. 2016. View Article : Google Scholar : PubMed/NCBI

25 

Leroux P and Marret S: PAI-1/t-PA ratio in cord blood: A potential index of brain haemorrhage risk in extreme preterms. Arch Dis Child Fetal Neonatal Ed. 98:F281–F282. 2013. View Article : Google Scholar : PubMed/NCBI

26 

Potapov O and Kmyta O: Changes of focal and brainstem neurologic signs in patients with traumatic brain injury and their dependence on the-675 4G/5G polymorphism in the PAI-1 gene. Georgian Med News. 45–51. 2014.(In Russian). PubMed/NCBI

27 

Knight EJ, Testini P, Min HK, Gibson WS, Gorny KR, Favazza CP, Felmlee JP, Kim I, Welker KM, Clayton DA, et al: Motor and nonmotor circuitry activation induced by subthalamic nucleus deep brain stimulation in patients with parkinson disease: Intraoperative functional magnetic resonance imaging for deep brain stimulation. Mayo Clin Proc. 90:773–785. 2015. View Article : Google Scholar : PubMed/NCBI

28 

Pallavaram S, D'Haese PF, Lake W, Konrad PE, Dawant BM and Neimat JS: Fully automated targeting using nonrigid image registration matches accuracy and exceeds precision of best manual approaches to subthalamic deep brain stimulation targeting in Parkinson disease. Neurosurgery. 76:756–765. 2015. View Article : Google Scholar : PubMed/NCBI

29 

Wagenbreth C, Zaehle T, Galazky I, Voges J, Guitart-Masip M, Heinze HJ and Düzel E: Deep brain stimulation of the subthalamic nucleus modulates reward processing and action selection in Parkinson patients. J Neurol. 262:1541–1547. 2015. View Article : Google Scholar : PubMed/NCBI

30 

Minami Y, Horikawa K, Akiyama M and Shibata S: Restricted feeding induces daily expression of clock genes and Pai-1 mRNA in the heart of Clock mutant mice. FEBS Lett. 526:115–118. 2002. View Article : Google Scholar : PubMed/NCBI

31 

Cho KS, Kwon KJ, Choi CS, Jeon SJ, Kim KC, Park JH, Ko HM, Lee SH, Cheong JH, Ryu JH, et al: Valproic acid induces astrocyte-dependent neurite outgrowth from cultured rat primary cortical neuron via modulation of tPA/PAI-1 activity. Glia. 61:694–709. 2013. View Article : Google Scholar : PubMed/NCBI

32 

Dietzmann K, von Bossanyi P, Krause D, Wittig H, Mawrin C and Kirches E: Expression of the plasminogen activator system and the inhibitors PAI-1 and PAI-2 in posttraumatic lesions of the CNS and brain injuries following dramatic circulatory arrests: An immunohistochemical study. Pathol Res Pract. 196:15–21. 2000. View Article : Google Scholar : PubMed/NCBI

33 

Zervos IA, Nikolaidis E, Lavrentiadou SN, Tsantarliotou MP, Eleftheriadou EK, Papapanagiotou EP, Fletouris DJ, Georgiadis M and Taitzoglou IA: Endosulfan-induced lipid peroxidation in rat brain and its effect on t-PA and PAI-1: Ameliorating effect of vitamins C and E. J Toxicol Sci. 36:423–433. 2011. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Pan H, Zhao Y, Zhai Z, Zheng J, Zhou Y, Zhai Q, Cao X, Tian J and Zhao L: Role of plasminogen activator inhibitor‑1 in the diagnosis and prognosis of patients with Parkinson's disease. Exp Ther Med 15: 5517-5522, 2018.
APA
Pan, H., Zhao, Y., Zhai, Z., Zheng, J., Zhou, Y., Zhai, Q. ... Zhao, L. (2018). Role of plasminogen activator inhibitor‑1 in the diagnosis and prognosis of patients with Parkinson's disease. Experimental and Therapeutic Medicine, 15, 5517-5522. https://doi.org/10.3892/etm.2018.6076
MLA
Pan, H., Zhao, Y., Zhai, Z., Zheng, J., Zhou, Y., Zhai, Q., Cao, X., Tian, J., Zhao, L."Role of plasminogen activator inhibitor‑1 in the diagnosis and prognosis of patients with Parkinson's disease". Experimental and Therapeutic Medicine 15.6 (2018): 5517-5522.
Chicago
Pan, H., Zhao, Y., Zhai, Z., Zheng, J., Zhou, Y., Zhai, Q., Cao, X., Tian, J., Zhao, L."Role of plasminogen activator inhibitor‑1 in the diagnosis and prognosis of patients with Parkinson's disease". Experimental and Therapeutic Medicine 15, no. 6 (2018): 5517-5522. https://doi.org/10.3892/etm.2018.6076
Copy and paste a formatted citation
x
Spandidos Publications style
Pan H, Zhao Y, Zhai Z, Zheng J, Zhou Y, Zhai Q, Cao X, Tian J and Zhao L: Role of plasminogen activator inhibitor‑1 in the diagnosis and prognosis of patients with Parkinson's disease. Exp Ther Med 15: 5517-5522, 2018.
APA
Pan, H., Zhao, Y., Zhai, Z., Zheng, J., Zhou, Y., Zhai, Q. ... Zhao, L. (2018). Role of plasminogen activator inhibitor‑1 in the diagnosis and prognosis of patients with Parkinson's disease. Experimental and Therapeutic Medicine, 15, 5517-5522. https://doi.org/10.3892/etm.2018.6076
MLA
Pan, H., Zhao, Y., Zhai, Z., Zheng, J., Zhou, Y., Zhai, Q., Cao, X., Tian, J., Zhao, L."Role of plasminogen activator inhibitor‑1 in the diagnosis and prognosis of patients with Parkinson's disease". Experimental and Therapeutic Medicine 15.6 (2018): 5517-5522.
Chicago
Pan, H., Zhao, Y., Zhai, Z., Zheng, J., Zhou, Y., Zhai, Q., Cao, X., Tian, J., Zhao, L."Role of plasminogen activator inhibitor‑1 in the diagnosis and prognosis of patients with Parkinson's disease". Experimental and Therapeutic Medicine 15, no. 6 (2018): 5517-5522. https://doi.org/10.3892/etm.2018.6076
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team